Navigation Links
NJ stroke researchers report advances in spatial neglect research at AAN Conference
Date:4/10/2012

West Orange, NJ. April 11, 2012. Anna M. Barrett, MD will represent Kessler Foundation's Stroke Rehabilitation Research Laboratory at the upcoming American Academy of Neurology Conference at the Ernest N. Morial Convention Center in New Orleans, LA, April 21 April 28. Four abstracts will be presented representing the Laboratory's collaborative investigation of the neurocognitive disorder of spatial neglect after right-brain stroke. Spatial neglect is a hidden disability of functional vision that hinders rehabilitation and recovery, affecting up to half of stroke survivors in the days and weeks after stroke.

Kessler Foundation's Stroke Rehabilitation Research Laboratory is a leader in establishing new clinical practice guidelines to reliably identify and treat this disabling disorder, through the Kessler Foundation Neglect Assessment Process (KF-NAP), which will be presented at the meeting. A.M. Barrett, MD, Director of Stroke Rehabilitation and Peii Chen, PhD, research scientist at Kessler Foundation will be presenting on this process with Kessler Foundation's collaborators, including Kimberly Hreha, OTR, Kessler Institute for Rehabilitation, Anne Foundas, MD, LSU Health Sciences Center, Louisiana State University, Kelly Goedert, PhD, Seton Hall University, Raymond Boston, PhD, University of Pennsylvania, Priyanka Shah and Amit Chaudhari, University of Medicine & Dentistry of New Jersey, and Paola Fortis, PhD, Center for Neurocognitive Rehabilitation, University of Trento, Italy. Dr. Barrett, a Professor at UMDNJ-New Jersey Medical School and Chief of Neurorehabilitation Program Innovation at Kessler Institute, is also the current president of the American Society for Neurorehabilitation (ASNR).

The Kessler Foundation Stroke Research Laboratory applies advances in spatial neglect research to clinical care, and will present two abstracts on the exciting prism treatment approach to this disorder. "Our goal is to develop guidelines for assigning prism treatment, based on behavior or brain imaging during the first weeks after stroke," commented Dr. Chen. The Stroke Laboratory raises professional awareness of this under-recognized stroke complication through the multidisciplinary Network for Spatial Neglect. The Network for Spatial Neglect was launched at the 2011 ASNR conference by Drs. Barrett and Chen, Kimberly Hreha, and Robin Hedeman of Kessler Institute.

Topics for the upcoming AAN meeting are:

  • Chen P, Hreha K, Fortis P, Goedert KM, Barrett AM. Using the Catherine Bergego Scale (CBS) in rehabilitation of spatial neglect: Kessler Foundation Neglect Assessment Process (KF-NAP).
  • Barrett AM, Goedert KM, Chen P, Boston R. Dissociated response to prism adaptation "aiming" spatial-motor bias, not "where" perceptual-attentional bias, is key.
  • Chaudhari A, Chen P, Goedert KM, Barrett AM. Retrospective analysis suggests BIT may sensitively diagnose "Where" perceptual-attentional neglect, in stroke survivors having less disability.
  • Shah P, Chen P, Goedert KM, Foundas AL, Barrett AM. Integrity of medial visuomotor pathway predicts better recovery in neglect patients receiving prism adaptation treatment.


'/>"/>

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Related medicine news :

1. Could Menthol Cigarettes Pose Even Higher Stroke Risk?
2. Predictors identified for rehospitalization among post-acute stroke patients
3. Stroke experts write a doctors guide for minimizing the risk of stroke
4. When Paramedics Suspect Stroke, Theyre Usually Right
5. Closing hole in the heart no better than drugs in preventing strokes
6. Half of Stroke Victims Dont Call 911, Research Shows
7. Art improves stroke survivors quality of life
8. Moderate drinking associated with lower risk of stroke in women
9. Study finds expensive procedure no more effective than medical therapy to prevent strokes
10. Brain Scans Overused on U.S. Stroke Patients, Study Says
11. Physicians order costly, redundant neuroimaging for stroke patients, study says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Military Officers Association of America (MOAA) announced ... Veterans Affairs, retired Marine Col. Thomas G. Bowman. , Bowman currently serves as the ... an intimacy with the issues and challenges veterans face with the VA. Following a ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Aesthetic ... facelift . Dr. Talei has come up with a proprietary technique that he calls ... lifts tissues that have dropped. For all ages, patients can expect to look refreshed, ...
(Date:6/23/2017)... Santa Monica, CA (PRWEB) , ... June 23, 2017 , ... ... PureLife as the endorsed amalgam separator supplier for CDA members. As part of the ... a reduced price of $99, saving more than $400 off the retail value. This ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: